Barclays raised the firm’s price target on Incyte (INCY) to $115 from $101 and keeps an Overweight rating on the shares. The firm updated the company’s model ahead of data releases in December.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INCY:
- Vanguard S&P 500 ETF (VOO) Daily Update, 11/21/2025
- Incyte’s Promising Pipeline and Market Surge: A Balanced Hold Rating Amid Future Uncertainties
- Vanguard S&P 500 ETF (VOO) Daily Update, 11/20/2025
- Vanguard S&P 500 ETF (VOO) Daily Update, 11/19/2025
- Early notable gainers among liquid option names on November 18th